Skip to main content

Peer Review reports

From: Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line

Original Submission
29 Jun 2021 Submitted Original manuscript
2 Aug 2021 Reviewed Reviewer Report
8 Aug 2021 Reviewed Reviewer Report
31 Aug 2021 Author responded Author comments - I. Nolte
Resubmission - Version 2
31 Aug 2021 Submitted Manuscript version 2
Publishing
24 Sep 2021 Editorially accepted
8 Oct 2021 Article published 10.1186/s12885-021-08836-y

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us